Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Ended earlyNCT01752569What this trial is testingSelumetinib in Patients With Kaposi's SarcomaWho this might be right forAIDS-related Kaposi's Sarcoma Sheffield Teaching Hospitals NHS Foundation Trust 19
Large-scale testing (Phase 3)Study completedNCT00002319What this trial is testingDOX-SL in the Treatment of AIDS-Related Kaposi's SarcomaWho this might be right forSarcoma, KaposiHIV Infections Sequus Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00000807What this trial is testingPhase II Evaluation of Low-Dose Oral Etoposide for the Treatment of Relapsed or Progressed AIDS-Related Kaposi's Sarcoma After Systemic ChemotherapyWho this might be right forSarcoma, KaposiHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 41
Early research (Phase 1)Study completedNCT02595866What this trial is testingTesting the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and CancerWho this might be right forAIDS-Related Non-Hodgkin LymphomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+16 more National Cancer Institute (NCI) 58
Testing effectiveness (Phase 2)Study completedNCT00019188What this trial is testingInterleukin-12 in Treating Patients With AIDS-Related Kaposi's SarcomaWho this might be right forEpidemic Kaposi's SarcomaRecurrent Kaposi's Sarcoma National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT02201420What this trial is testingEvaluation of Tc 99m Tilmanocept Localization in Primary Cutaneous Kaposi's Sarcoma and Lymphatic Drainage by SPECT/CTWho this might be right forKaposi's Sarcoma Navidea Biopharmaceuticals 5
Early research (Phase 1)Study completedNCT00000660What this trial is testingPhase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's SarcomaWho this might be right forSarcoma, KaposiHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 24
Testing effectiveness (Phase 2)Study completedNCT00019123What this trial is testingThalidomide in Treating Patients With HIV-Associated Kaposi's SarcomaWho this might be right forSarcoma National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT03601806What this trial is testingPomalidomide in Treating Patients With Kaposi Sarcoma and Human Immunodeficiency Virus InfectionWho this might be right forHuman Immunodeficiency Virus 1 PositiveSkin Kaposi Sarcoma AIDS Malignancy Consortium 26
Not applicableWithdrawnNCT00093678What this trial is testingCelecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced CancerWho this might be right forCachexiaLymphomaMelanoma (Skin)+4 more Eastern Cooperative Oncology Group
Not applicableStudy completedNCT01764360What this trial is testingStrategies to Improve Kaposi Sarcoma (KS) Outcomes in ZimbabweWho this might be right forKaposi Sarcoma (KS)HIV University of Colorado, Denver 1,024
Early research (Phase 1)Study completedNCT00000695What this trial is testingOpen Label Phase I Study To Evaluate the Safety of Combination Therapy With AZT and Interferon-Beta in Patients With AIDS Related Kaposi's SarcomaWho this might be right forSarcoma, KaposiHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 36
Early research (Phase 1)Study completedNCT00003207What this trial is testingLiposomal Doxorubicin and PSC 833 in Treating Patients With AIDS-Related Kaposi's Sarcoma or Other Advanced CancersWho this might be right forSarcomaUnspecified Adult Solid Tumor, Protocol Specific Washington University School of Medicine 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT03038672What this trial is testingNivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell LymphomasWho this might be right forALK-Positive Large B-Cell LymphomaDiffuse Large B-Cell Lymphoma Activated B-Cell TypeDiffuse Large B-Cell Lymphoma Associated With Chronic Inflammation+32 more National Cancer Institute (NCI) 54
Very early researchEnded earlyNCT02080416What this trial is testingNelfinavir for the Treatment of Gammaherpesvirus-Related TumorsWho this might be right forNon-Hodgkin LymphomaHodgkin LymphomaKaposi Sarcoma+4 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 1
Large-scale testing (Phase 3)UnknownNCT00002318What this trial is testingA Comparison of DOX-SL Versus Adriamycin Plus Bleomycin Plus Vincristine in the Treatment of Severe AIDS-Related Kaposi's SarcomaWho this might be right forSarcoma, KaposiHIV Infections Sequus Pharmaceuticals 225
Early research (Phase 1)Study completedNCT00000725What this trial is testingA Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment of AIDS-Associated Kaposi's SarcomaWho this might be right forSarcoma, KaposiHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 56
Early research (Phase 1)Active Not RecruitingNCT04514484What this trial is testingTesting the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIVWho this might be right forAdvanced Differentiated Thyroid Gland CarcinomaAdvanced Head and Neck CarcinomaAdvanced Hepatocellular Carcinoma+60 more National Cancer Institute (NCI) 8
Not applicableStudy completedNCT00096538What this trial is testingValganciclovir in Treating Patients With Classic Non-HIV-Associated Kaposi's SarcomaWho this might be right forSarcoma Memorial Sloan Kettering Cancer Center 6